Stephen Rocamboli - Apr 28, 2022 Form 3 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Benjamin Looker
Stock symbol
ESPR
Transactions as of
Apr 28, 2022
Transactions value $
$0
Form type
3
Date filed
4/28/2022, 04:37 PM
Next filing
May 17, 2022

No securities are beneficially owned.